 After his considerable tenure at SmithKline & French came to an end in 1986, Ganellin has continued to remain active in the affairs of medicinal chemistry.Shortly before leaving, he was awarded his D.Sc.from London University for his research and publications on histaminergic drugs and elected as a Fellow of the Royal Society (the UK's National Academy of Science).